4//SEC Filing
Struthers Richard Scott 4
Accession 0000950170-25-043401
CIK 0001658247other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 6:31 PM ET
Size
11.1 KB
Accession
0000950170-25-043401
Insider Transaction Report
Form 4
Struthers Richard Scott
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2025-03-19$34.17/sh−16,463$562,541→ 330,022 total - Sale
Common Stock
2025-03-19$34.83/sh−875$30,476→ 329,147 total
Holdings
- 570,805(indirect: By Trust)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 100,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents the number of shares of common stock sold by the Issuer to cover the Reporting Person's tax withholding obligation upon the vesting of Restricted Stock Units granted on February 28, 2022, March 1, 2023, and March 4, 2024. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The common stock was sold in open market transactions on the transaction date, with a volume weighted average sales price of $34.17 per share. The range of sales prices on the transaction date was $33.78 to $34.77 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
- [F3]Represents the number of shares of common stock sold by the Issuer to cover the Reporting Person's tax withholding obligation upon the vesting of Restricted Stock Units granted on February 28, 2022, March 1, 2023, and March 4, 2024. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F4]The common stock was sold in open market transactions on the transaction date, with a volume weighted average sales price of $34.83 per share. The range of sales prices on the transaction date was $34.78 to $35.00 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001746298
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 6:31 PM ET
- Size
- 11.1 KB